DO SOFT COST-CONTROL MEASURES CHANGE PRODUCTIVITY? - PREFERRED STATIN PRESCRIBING IN GERMANY
Version 2 2024-06-06, 03:35Version 2 2024-06-06, 03:35
Version 1 2022-11-15, 01:55Version 1 2022-11-15, 01:55
conference contribution
posted on 2022-11-15, 01:55authored byD Avdic, KE Blankart
How can organizations change experts' practice styles? We analyze physician responses to changes in preferred drug policies in a class of drugs with heterogenous efficacy-safety-cost profiles. Aimed at reducing inefficiencies, preferred drug policies recommend a preferred drug among a set of equivalent drugs. Policies include an indirect financial risk to physicians when non-compliant. We empirically explore physician responses to changes in the number of preferred drugs. We develop a typology based on a physician's compliance with the standard pre-/post-policy. If at all, we do not find strong effects suggesting that preferred drug policies were not very effective in changing practice.